Translumina a fully integrated product development and manufacturing company with manufacturing facilities in Germany and India. It commercializes our products in over 50 countries globally through 2 distinct business entities, International and India.

Sirolimus Eluting CoCr Coronary Stent System
Yukon Chrome PC

The Translumina Yukon Choice PC drug-eluting stent, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical results


In two independent trials ISARTEST 3 and ISAR-TEST 4 the Yukon Choice PC showed improved long-term performance compared to 1st. Generation DES over a time period of 10 years clinical follow-up in the randomized controlled clinical trial.

An additional sub-group analysis shows also benefit in difficult patient groups like diabetics and patients with acute myocardial infarkt.

Due to this excellent clinical outcome the Yukon Choice PC is recommended by the latest ESC guidelines for myocardial revascularization

Sirolimus - Elution CoCr Coronary Stent System
Yukon Choice PC

The Translumina Yukon Choice PC drug-eluting stent, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical results.


In two independent trials ISARTEST 3 and ISAR-TEST 4 the Yukon Choice PC showed improved long-term performance compared to 1st. Generation DES over a time period of 10 years clinical follow-up in the randomized controlled clinical trial.

An additional sub-group analysis shows also benefits in difficult patient groups like diabetics and patients with acute myocardial infarct.

Due to this excellent clinical outcome, the Yukon Choice PC is recommended by the latest ESC guidelines for myocardial revascularization

Polimer - Free Sirolimus Eluting Stent
VIVO ISAR

Polymers (Durable or Biocompatible) are an integral part of the Drug Release Matrix in current generation DES as they ensure the Release Kinetics of the active drug, the critical determinant of antirestenotic efficacy. However, the mechanical properties of the Metallic Cage and Aggressive Inflammatory Reactions during polymer erosion are known to cause.

  • Persistent Fibrin Deposition
  • Delayed Endothelialisation
  • Chronic Inflammation
  • Persistent Platelet Activation

Current DES Polymers are often associated with Flaking, Webbing, and Peeling which leads to impaired action of active drugs.
VIVO ISAR is an innovative technology that eliminates the use of Polymer by using Dual Drug Technology: Sirolimus and Probucol

PTCA Dilatation Catheter
Cathy n°4


The Translumina Cathy n°4 represents the next-generation catheter technology with an optimum in pushability and trackability. This Balloon Catheter has been developed in order to increase the success rate when crossing the lesions. Improvements in soft and hard high-tech materials result in a perfect product balance for easy navigation.
       - the new designed luer
       - the new distal shaft
       - the new flexible tip